China’s Duality Biotherapeutics Seeks IPO to Accelerate ADC Development

Mabwell receives approval for Phase III trial of urothelial carcinoma drug in China

LigaChem collaborates with CStone on LCB71, showing efficacy in solid tumors and hematological cancers in...

Enfortumab vedotin plus pembrolizumab approved in Europe for urothelial carcinoma